(Q36106717)

12 August 2017

1 reference

title

Review of the cost effectiveness of immunisation strategies for the control of epidemic meningococcal meningitis (English)

1 reference

12 August 2017

1 reference

Mark A Miller

1

1 reference

12 August 2017

Cathryn K Shahab

series ordinal

2

1 reference

12 August 2017

publication date

1 January 2005

1 reference

12 August 2017

1 reference

12 August 2017

volume

23

1 reference

12 August 2017

issue

4

1 reference

12 August 2017

page(s)

333-343

1 reference

Comparison of cost-effectiveness of preventive and reactive mass immunization campaigns against meningococcal meningitis in West Africa: a theoretical modeling analysis

12 August 2017

cites work

1 reference

12 December 2020

Meningococcal disease: public health burden and control

1 reference

12 December 2020

A cost-effectiveness analysis of vaccination strategies against N. meningitidis meningitis in sub-Saharan African countries

1 reference

12 December 2020

Evaluation of meningococcal meningitis vaccination strategies for the meningitis belt in Africa

1 reference

12 December 2020

Clinical Efficacy of Meningococcus Group A Capsular Polysaccharide Vaccine in Children Three Months to Five Years of Age

1 reference

12 December 2020

Epidemiology of bacterial meningitis in Niamey, Niger, 1981-96.

1 reference

12 December 2020

Shift in the age-distribution of meningococcal disease as predictor of an epidemic?

1 reference

12 December 2020

Control of meningococcal infection in the African meningitis belt by selective vaccination

1 reference

12 December 2020

Immunologic response of man to group B meningococcal polysaccharide vaccines.

1 reference

12 December 2020

Timely detection of meningococcal meningitis epidemics in Africa

1 reference

12 December 2020

Access to essential drugs in poor countries: a lost battle?

1 reference

12 December 2020

Prospects for the prevention of meningococcal disease: special reference to group B

1 reference

12 December 2020

Control of epidemic meningococcal meningitis by mass vaccination. II. Persistence of antibody four years after vaccination

1 reference

12 December 2020

Meningococcal disease in the Republic of Ireland: 1995.

1 reference

12 December 2020

Should college students be vaccinated against meningococcal disease? A cost-benefit analysis

1 reference

12 December 2020

Vaccines for prevention of meningococcal disease

1 reference

12 December 2020

Cost-benefit analysis of a regional system for vaccination against pneumonia, meningitis type B, and typhoid fever

1 reference

12 December 2020

Detection of meningitis epidemics in Africa: a population-based analysis

1 reference

12 December 2020

Neisseria meningitidis serogroups W135 and A were equally prevalent among meningitis cases occurring at the end of the 2001 epidemics in Burkina Faso and Niger

1 reference

12 December 2020

Human immunity to the meningococcus. IV. Immunogenicity of group A and group C meningococcal polysaccharides in human volunteers

1 reference

12 December 2020

Age-distribution of meningococcal disease as predictor of epidemics

1 reference

12 December 2020

Immune response to revaccination with meningococcal A and C polysaccharides in Gambian children following repeated immunisation during early childhood.

1 reference

12 December 2020

The incidence of bacterial meningitis in the Netherlands--a comparison of three registration systems, 1977-1982

1 reference

12 December 2020

A rebuttal: epidemic and endemic meningococcal meningitis in sub-Saharan Africa can be prevented now by routine immunization with group A meningococcal capsular polysaccharide vaccine

1 reference

12 December 2020

Safety and immunogenicity of a serogroups A/C Neisseria meningitidis oligosaccharide-protein conjugate vaccine in young children. A randomized controlled trial

1 reference

12 December 2020

The cost of unsafe injections

1 reference

12 December 2020

An Epidemic of Meningococcal Disease in Karachi (Pakistan): A Study of Children

1 reference

12 December 2020

Priority during a meningitis epidemic: vaccination or treatment?

1 reference

12 December 2020

Meningococcal disease and season in sub-Saharan Africa

1 reference

12 December 2020

Safety and immunogenicity of three doses of a Neisseria meningitidis A + C diphtheria conjugate vaccine in infants from Niger

1 reference

12 December 2020

Meningitis outbreaks and vaccination strategy

1 reference

12 December 2020

"Love's labours lost": failure to implement mass vaccination against group A meningococcal meningitis in sub-Saharan Africa

1 reference

12 December 2020

Meningococcal meningitis among Rwandan refugees: diagnosis, management, and outcome in a field hospital

1 reference

12 December 2020

[Changes in epidemic features of epidemic cerebrospinal meningitis after vaccination with purified meningococcal polysaccharide vaccine group A in Zhengzhou]

1 reference

12 December 2020

Should all college-bound freshmen receive meningococcal vaccine?

1 reference

12 December 2020

Epidemic of meningococcal meningitis in Bamako, Mali: epidemiological features and analysis of vaccine efficacy

1 reference

12 December 2020

Control of an epidemic of meningococcal meningitis in Central Africa

1 reference

12 December 2020

Observation on the epidemiologic efficacy for 9 years on epidemic meningococcal polysaccharide vaccine of group A by district immunization method

1 reference

12 December 2020

Epidemic meningococcal disease in Nairobi, Kenya, 1989. The Kenya/Centers for Disease Control (CDC) Meningitis Study Group

1 reference

12 December 2020

Meningococcal vaccines in prevention and control of meningitis

1 reference

12 December 2020

A severe epidemic of meningococcal meningitis in Nigeria, 1996.

1 reference

12 December 2020

Treatment and prevention of meningococcal disease.

1 reference

12 December 2020

Age-specific differences in duration of clinical protection after vaccination with meningococcal polysaccharide A vaccine

1 reference

12 December 2020

Control of epidemic group A meningococcal meningitis in Nepal

1 reference

12 December 2020

Serum antibodies to capsular polysaccharide vaccine of group A Neissera meningitidis followed for three years in infants and children

1 reference

12 December 2020

[Meningococcal C disease epidemic in Galicia 1996: the decision making process]

1 reference

12 December 2020

Duration of antibody response after meningococcal polysaccharide vaccination in US Air Force personnel

1 reference

12 December 2020

Kinetics of Antibody Production to Group A and Group C Meningococcal Polysaccharide Vaccines Administered during the First Six Years of Life: Prospects for Routine Immunization of Infants and Children

1 reference

12 December 2020

Impact of a mass immunization campaign against serogroup C meningococcus in the Province of Quebec, Canada.

1 reference

12 December 2020

CEREBROSPINAL MENINGITIS IN AFRICA

1 reference

12 December 2020

Report of the first hemispheric meeting on meningococcal disease

1 reference

12 December 2020

Epidemiologic aspects of purulent meningitis in tropical Africa (1052 cases observed in Dakar)

1 reference

12 December 2020

10.2165/00019053-200523040-00004

Identifiers

DOI

1 reference

Dimensions Publication ID

12 August 2017

1022837095

0 references

1 reference